Log In
Print
BCIQ
Print
Print this Print this
 

JVS-100

  Manage Alerts
Collapse Summary General Information
Company Juventas Therapeutics Inc.
DescriptionNon-viral DNA plasmid carrying chemokine CXC motif ligand 12 (CXCL12; SDF-1)
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Non-viral vector

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today